AddLife´s group management
The CEO, Kristina Willgård, shall manage the operations in accordance with the Companies Act and within the framework established by the Board of Directors. The work and role of the CEO and the division of duties between the Board of Directors and the CEO are detailed in a written set of instructions set out by the Board of Directors (“Instructions to the CEO”). The Board of Directors continuously evaluates the work of the CEO. In consultation with the Chairman, the CEO has prepared the information needed to make decisions at Board meetings and has presented reports and reasoned proposals for decisions.
The CEO shall lead the work of the group management and make decisions in consultation with the other members of the group management. In addition to Kristina Willgård, group management also includes Martin Almgren, CFO and Business Area Manager Medtech, Peter Simonsbacka, Business Area Manager Labtech, Ulrika Hellman, Head of M&A and Ove Sandin, Senior Advisor. Martin Almgren will leave his position as CFO. Martin has during the year replaced Ove Sandin, previous Business Area Manager Medtech, who is now Senior Advisor. Christina Rubenhag has been reqruited as new CFO and will start her position during the second quarter 2022. Group management has regular business reviews under the management of the CEO.
During the financial year, the Group’s operations were organised into two business areas – Labtech and Medtech. Operations are conducted in subsidiaries in the Nordic region, Central and Eastern Europe, Australia and China. Each operating Company has a board of directors in which the Company’s CEO and senior executives from the business area are represented. Each company president reports to a business division manager or business area manager, who, in turn reports to the CEO for AddLife AB.